Company / AR per Share
Neurocrine Biosciences AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$6.91
FY2025
5-year range
$1.98 / $6.91
FY2021-FY2025
Trend
+42.3%
vs FY2024
Sector context
#11 of 115
Health Care
What the data says
Among 115 Health Care companies, Neurocrine Biosciences is in the top 10% for ar per share. AR per Share has increased for 9 consecutive years, from $0.00 in FY2016 to $6.91 in FY2025.
Based on SEC 10-K filings.
6.91 in FY2025 with a 5-year CAGR of +32.3%. Top quartile in the Health Care sector.
Improved from $4.55 to $6.91 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +23.3%
- 5-Year CAGR
- +32.3%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 115This company $6.91 Sector average $27.09
▼
-74.5% below sector average
Key checks
Key Insights
- Neurocrine Biosciences's ar per share has grown for 8 consecutive years.
- In FY2025, ar per share increased 42.3% year-over-year.
- Ranks #11 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.91 | +42.3% |
| FY2024 | $4.85 | +6.6% |
| FY2023 | $4.55 | +23.4% |
| FY2022 | $3.69 | +85.9% |
| FY2021 | $1.98 | +16.6% |
| FY2020 | $1.70 | +22.1% |
| FY2019 | $1.39 | +115.7% |
| FY2018 | $0.65 | +80.5% |
| FY2017 | $0.36 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026